FDA Guidance on Assessment of Abuse Potential of Drugs

An important consideration for the development of new drugs is whether they can be abused - the FDA released a guidance document in January 2017 - detailing considerations in the assessment of abuse potential for drugs . The document defines drugs that have CNS activity and produce euphoria (or other changes in mood), hallucinations, and effects consistent with CNS depressants or stimulants as…